Assessment of health‐related quality of life and health utilities in Australian patients with cirrhosis
Steven M McPhail,
Samath Amarasena,
Katherine A Stuart,
Kelly Hayward,
Rohit Gupta,
David Brain,
Gunter Hartel,
Tony Rahman,
Paul J Clark,
Christina M Bernardes,
Richard Skoien,
Benjamin Mckillen,
Andrew Lee,
Leshni Pillay,
Lei Lin,
Myat Myat Khaing,
Leigh Horsfall,
Elizabeth E Powell,
Patricia C Valery
Affiliations
Steven M McPhail
Australian Centre for Health Services Innovation and Centre for Healthcare Transformation, School of Public Health and Social Work Queensland University of Technology Brisbane Queensland Australia
Samath Amarasena
Department of Gastroenterology and Hepatology Royal Brisbane and Women's Hospital Brisbane Queensland Australia
Katherine A Stuart
Department of Gastroenterology and Hepatology Princess Alexandra Hospital Brisbane Queensland Australia
Kelly Hayward
Centre for Liver Disease Research, Translational Research Institute, Faculty of Medicine The University of Queensland Brisbane Queensland Australia
Rohit Gupta
Gastroenterology and Hepatology Department The Prince Charles Hospital Brisbane Queensland Australia
David Brain
Australian Centre for Health Services Innovation and Centre for Healthcare Transformation, School of Public Health and Social Work Queensland University of Technology Brisbane Queensland Australia
Gunter Hartel
QIMR Berghofer Medical Research Institute Brisbane Queensland Australia
Tony Rahman
Gastroenterology and Hepatology Department The Prince Charles Hospital Brisbane Queensland Australia
Paul J Clark
Department of Gastroenterology and Hepatology Mater Hospitals Brisbane Queensland Australia
Christina M Bernardes
Gastroenterology and Hepatology Department The Prince Charles Hospital Brisbane Queensland Australia
Richard Skoien
Department of Gastroenterology and Hepatology Royal Brisbane and Women's Hospital Brisbane Queensland Australia
Benjamin Mckillen
Department of Gastroenterology and Hepatology Royal Brisbane and Women's Hospital Brisbane Queensland Australia
Andrew Lee
Department of Gastroenterology and Hepatology Mater Hospitals Brisbane Queensland Australia
Leshni Pillay
Department of Gastroenterology and Hepatology Logan Hospital Brisbane Queensland Australia
Lei Lin
Gastroenterology and Hepatology Department The Prince Charles Hospital Brisbane Queensland Australia
Myat Myat Khaing
Gastroenterology and Hepatology Department The Prince Charles Hospital Brisbane Queensland Australia
Leigh Horsfall
Department of Gastroenterology and Hepatology Princess Alexandra Hospital Brisbane Queensland Australia
Elizabeth E Powell
Department of Gastroenterology and Hepatology Princess Alexandra Hospital Brisbane Queensland Australia
Patricia C Valery
QIMR Berghofer Medical Research Institute Brisbane Queensland Australia
Abstract Background and Aim Health‐related quality‐of‐life measurements are important to understand lived experiences of patients who have cirrhosis. These measures also inform economic evaluations by modelling quality‐adjusted life years (QALYs). We aimed to describe health‐related quality of life, specifically multiattribute utility (scale anchors of death = 0.00 and full health = 1.00), across various stages and etiologies of cirrhosis. Methods Face‐to‐face interviews were used to collect Short Form 36 (SF‐36) questionnaire responses from CirCare study participants with cirrhosis (June 2017 to December 2018). The severity of cirrhosis was assessed using the Child‐Pugh score classified as class A (5–6 points), B (7–9), or C (10–15) and by the absence (“compensated”) versus presence (“decompensated”) of cirrhosis‐related complications. Results Patients (n = 562, average 59.8 years [SD = 11.0], male 69.9%) had a range of primary etiologies (alcohol‐related 35.2%, chronic hepatitis C 25.4%, non‐alcoholic fatty liver disease (NAFLD) 25.1%, chronic hepatitis B 5.9%, “other” 8.4%). Significantly lower (all P < 0.001) mean multiattribute utility was observed in the health states of patients with decompensated (mean = 0.62, SD = 0.15) versus compensated cirrhosis (mean = 0.68, SD = 0.12), Child‐Pugh class C (mean = 0.59, SD = 0.15) or B (mean = 0.63, SD = 0.15) versus A (mean = 0.68, SD = 0.16), and between those of working age (18–64 years; mean = 0.64, SD = 0.16) versus those aged 65+ years (mean = 0.70, SD = 0.16). The greatest decrements in health‐related quality of life relative to Australian population norms were observed across physical SF‐36 domains. Conclusions Persons with more advanced cirrhosis report greater life impacts. Estimates from this study are suitable for informing economic evaluations, particularly cost‐utility modelling, which captures the benefits of effective prevention, surveillance, and treatments on both the quality and quantity of patients' lives.